Kelley Shannon T. - 15 Aug 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
General Counsel
Signature
/s/ Mardi Dier, as Attorney-in-Fact
Issuer symbol
MDGL
Transactions as of
15 Aug 2024
Net transactions value
$0
Form type
4
Filing time
19 Aug 2024, 20:16:25 UTC
Previous filing
15 Aug 2024
Next filing
17 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Award $0 +5,215 +188% $0.000000 7,982 15 Aug 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDGL Stock Option (Right to Buy) Award $0 +7,820 $0.000000 7,820 15 Aug 2024 Common Stock 7,820 $244.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units, which vest as to 25% of the shares on each of August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028, provided the Reporting Person continues in service with the Issuer on each such date.
F2 The option vests as to 25% of the shares on the first anniversary of the date of grant (August 15, 2025) and, thereafter, 6.25% of the shares shall vest on each quarterly anniversary following the first anniversary, provided the Reporting Person continues in service with the Issuer on each such date.